Equities

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)1.59
  • Today's Change0.08 / 5.30%
  • Shares traded48.00k
  • 1 Year change-6.47%
  • Beta-0.0032
Data delayed at least 15 minutes, as of May 29 2024 08:18 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Jilin Province Huinan Changlong Bio-pharmacy Company Limited is principally engaged in the manufacture and distribution of Chinese medicines and pharmaceutical products. Its products are mainly sold under the brand names of Changlong and Qing Tong. Its primary products include tablets, capsules, bulk drug, membrane, pills, bulk drug, powder for injection, lyophilized powder for injection, small volume parenteral solutions, sterile bulk drug and solution. The Company is also engaged in the trading of biochemical medicine through its subsidiaries. Its principal subsidiaries include Jilin Province Huinan Changlong Pharmacy Trading Company Limited and Jilin Province Medicinal Plants Trading Company Limited.

  • Revenue in HKD (TTM)906.91m
  • Net income in HKD159.72m
  • Incorporated1996
  • Employees848.00
  • Location
    Jilin Province Huinan Changlong Bio-pharmacy Co LtdNo. 31 Beishan StreetChaoyang Town, Huinan CountyTONGHUA 135100ChinaCHN
  • Phone+86 4 358218333
  • Fax+86 4 358210005
  • Websitehttp://www.jlchanglong.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Tianda Pharmaceuticals Ltd532.09m-24.16m537.51m863.00--0.907947.141.01-0.0112-0.01120.24750.27540.53064.884.37616,557.40-2.49---3.84--48.02---4.70--0.8907-13.980.161--------------
Kintor Pharmaceutical Ltd0.00-1.14bn541.47m225.00--1.10-----2.66-2.660.001.100.000.1448--0.00-72.55-50.15-89.09-58.43---27.62---10,511.412.10--0.3566-------11.15---32.49--
Antengene Corporation Ltd72.53m-626.33m661.39m201.00--0.5349--9.12-1.02-1.020.11791.830.03580.97733.41360,861.30-30.91-53.57-36.46-58.9481.74---863.51-1,987.016.43--0.1491---57.97--3.38--202.03--
Sirnaomics Ltd0.00-614.32m663.42m145.00--2.11-----8.08-8.080.003.580.00----0.00-70.91---71.22--------------0.6176------10.88------
Genor Biopharma Holdings Ltd0.00-726.75m681.85m104.00--0.5229-----1.44-1.440.002.540.000.00--0.00-37.91-55.46-44.02-63.73--66.56---14,819.185.38--0.006---100.00--7.65---48.85--
Lee's Pharmaceutical Holdings Ltd1.05bn16.70m688.94m1.06k41.260.33794.410.65420.02840.02841.793.460.37131.8310.75996,247.900.703313.330.8817.7652.3561.921.8936.200.55263.900.09433.59-14.61-1.53-67.44-47.49-12.19-31.34
Transcenta Holding Limited58.03m-498.50m768.02m215.00--0.6916--13.23-1.22-1.220.14262.540.02812.051.49269,915.80-24.17---33.97--26.74---859.01--1.20-32.870.285---47.15---13.72------
Pak Fah Yeow International Ltd259.16m105.04m779.10m102.007.421.026.933.010.3370.3370.83162.460.29952.8822.182,540,765.0012.143.9912.604.1884.4580.7940.5321.276.9010.080.0062100.6876.0612.94250.6623.0218.83-8.06
Jbm (Healthcare) Ltd610.30m97.99m792.12m258.008.740.84475.321.300.10870.10870.67861.120.44065.884.102,000,994.007.563.339.044.9347.7045.9717.1710.971.4522.150.121113.8128.1114.51131.906.14-5.09--
Zhaoke Ophthalmology Ltd20.21m-414.95m819.21m313.00--0.3711--40.54-0.7629-0.76290.03724.040.0075--0.53164,557.39-15.43---17.27--75.98---2,053.54--5.32-47.540.1041------5.47------
Jilin Provnc Hnn Chnglng Bio-pharm CoLtd906.91m159.72m845.98m848.005.300.53036.910.93280.28510.28511.622.850.35872.182.941,069,475.006.327.679.1210.4869.4078.7917.6120.681.51--0.05157.22-0.00495.38-23.43-1.67-1.14--
Fusen Pharmaceutical Co Ltd609.54m-39.09m899.95m1.15k--1.48--1.48-0.0524-0.05240.81050.80980.41991.958.36530,961.10-2.690.9678-5.541.7452.9551.95-6.422.590.60960.7560.379727.9515.024.13-4.83--0.2124--
Brii Biosciences Ltd664.93k-188.41m904.96m128.00--0.2691--1,361.00-0.259-0.2590.00094.610.0002----5,194.75-5.60---5.84-------29,881.69------0.001---98.80--63.90------
Zhongzhi Pharmaceutical Holdings Ltd2.21bn175.42m915.42m2.64k5.120.81013.180.41440.20710.20712.611.311.122.5310.54835,806.808.957.6914.1511.7559.7360.448.016.730.894--0.142442.4612.2612.4153.0013.8617.653.22
JW (Cayman) Therapeutics Co Ltd187.36m-827.65m920.34m398.00--0.5045--4.91-2.01-2.010.45534.400.07041.6865.54470,755.80-31.11-39.77-35.21-44.0050.74---441.74-1,316.813.86-47.820.1592--19.32--9.23---19.87--
Hbm Holdings Ltd698.72m177.97m1.14bn177.006.111.165.321.630.24210.24210.9521.280.38863.903.013,947,544.009.88-54.6114.13-66.0497.7397.8125.43-400.283.286.980.3556--120.13127.06116.61---12.62--
Data as of May 29 2024. Currency figures normalised to Jilin Province Huinan Changlong Bio-pharmacy Co Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

0.02%Per cent of shares held by top holders
HolderShares% Held
FIL Investments Internationalas of 30 Jun 202332.00k0.02%
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.